In- Depth Research on Biovail Corp.

M2 Presswire, April, 2007

M2 PRESSWIRE-3 April 2007-Biotech News: In- Depth Research on Biovail Corp(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:03042007 In- Depth Research on Biovail Corp (NYSE:BVF) Biovail Corporation engages in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products utilizing various drug-delivery technologies in the United States and Canada.

The company principally focuses on central nervous system disorders, pain management, and cardiovascular diseases. It offers Zovirax Cream, an antiviral medication, for the treatment of herpes labialis; Wellbutrin XL to cure depression in adults; Ultram ER, an extended-release formulation of tramadol hydrochloride (HCl), used in the treatment of chronic pain in adults; and...